Earnings (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Calculations of Earnings (Loss) Per Share

The calculations of earnings (loss) per share are as follows:

	Three Months Ended March 31,
(In thousands, except per share amounts)	2019			2018
Basic earnings (loss) per Common Share:
Loss from continuing operations, net of tax	$	(7,977	)	$	(25,161	)
Net loss attributable to non-controlling interests		424			790
Net loss from continuing operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders	$	(7,553	)	$	(24,371	)
Loss from discontinued operations, net of tax	$	0		$	(3,354	)
Accretion of redemption preference on redeemable    convertible non-controlling interest - discontinued operations		0			(12,149	)
Net loss from discontinued operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders		0			(15,503	)
Net loss attributable to Allscripts Healthcare    Solutions, Inc. stockholders	$	(7,553	)	$	(39,874	)
Weighted-average common shares outstanding		169,957			179,882
Basic earnings (loss) from continuing operations per    Common Share	$	(0.04	)	$	(0.14	)
Basic income from discontinued operations per Common Share		0.00			(0.08	)
Net loss attributable to Allscripts Healthcare    Solutions, Inc. stockholders per Common Share	$	(0.04	)	$	(0.22	)
Diluted earnings (loss) per Common Share:
Loss from continuing operations, net of tax	$	(7,977	)	$	(25,161	)
Net loss attributable to non-controlling interests		424			790
Net loss from continuing operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders	$	(7,553	)	$	(24,371	)
Loss from discontinued operations, net of tax	$	0		$	(3,354	)
Accretion of redemption preference on redeemable    convertible non-controlling interest - discontinued operations		0			(12,149	)
Net loss from discontinued operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders		0			(15,503	)
Net loss attributable to Allscripts Healthcare    Solutions, Inc. stockholders	$	(7,553	)	$	(39,874	)
Weighted-average common shares outstanding		169,957			179,882
Plus: Dilutive effect of stock options, restricted stock unit    awards and warrants		0			0
Weighted-average common shares outstanding assuming    dilution		169,957			179,882
Diluted earnings (loss) from continuing operations per    Common Share	$	(0.04	)	$	(0.14	)
Diluted income from discontinued operations per Common Share		0.00			(0.08	)
Net loss attributable to Allscripts Healthcare    Solutions, Inc. stockholders per Common Share	$	(0.04	)	$	(0.22	)

Anti-Dilutive Stock Options, Restricted Stock Unit Awards and Warrants Excluded from Computation of Diluted Earnings (Loss) Per Share

The following stock options, restricted stock unit awards and warrants are not included in the computation of diluted earnings (loss) per share as the effect of including such stock options, restricted stock unit awards and warrants in the computation would be anti-dilutive:

	Three Months Ended March 31,
(In thousands)	2019		2018
Shares subject to anti-dilutive stock options, restricted stock    unit awards and warrants excluded from calculation		26,738		23,208